Search Results - "MONICI, P"

First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease by JHEE, S. S, FABBRI, Laura, PICCINNO, A, MONICI, P, MORAN, S, ZAROTSKY, V, TAN, E. Y, FRACKIEWICZ, E. J, SHIOVITZ, T

“…The objective of this study was to evaluate the safety, tolerability, maximum tolerated dose, pharmacokinetics, and pharmacodynamics of five fixed doses of…”
Get full text

Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo‐controlled, crossover study by Houghton, C. M., Langley, S. J., Singh, S. D., Holden, J., Monici Preti, A. P., Acerbi, D., Poli, G., Woodcock, A.

“…Background In response to the phasing out of chlorofluorocarbon (CFC) inhalers, a metered dose hydrofluoroalkane (HFA) formulation, Modulite (Chiesi…”
Get full text

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica by Maresta, A, Balducelli, M, Cantini, L, Casari, A, Chioin, R, Fabbri, M, Fontanelli, A, Monici Preti, P A, Repetto, S, De Servi, S

“…Trapidil is an antiplatelet drug with specific platelet-derived growth factor antagonism and antiproliferative effects in the rat and rabbit models after…”
Get full text

Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation by Marraro, G, Foresti, B, Casiraghi, G, Monici Preti, P

“…A follow-up was carried out on twenty-two children (thirteen of whom were newborn) who had been treated with porcine surfactant (Curosurf) for respiratory…”
Get more information

Selegiline versus oxiracetam in patients with Alzheimer-type dementia by Falsaperla, A, Monici Preti, P A, Oliani, C

“…The efficacy and tolerability of the monoamine oxidase B inhibitor selegiline and of the nootropic agent oxiracetam were compared in a single-blind,…”
Get more information

Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis by Bonardelli, P, Oliani, C, Monici Preti, P A, Pellicanó, P, Quattrocchi, G

“…Thirty patients aged 26 to 70 years with a history of chronic osteoarthritis of at least eight years were randomly assigned to receive 20 mg daily of…”
Get more information

Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacin by Cosmi, E.V., Cantini, L., Preti, P.A.Monici, Di Renzo, G.C., Abate, F., Balsotti, G., Carlomagno, G., Cirese, E., Indraccolo, R., La Sala, G.B., Mearini, L., Minozzi, M., Scarpello, F.

“…In an open study, 172 male and female adult patients with acute uncomplicated bacterial cystitis were randomly allocated to three treatment groups. Two groups…”
Get full text

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs by Roggeri, Daniela Paola, Roggeri, Alessandro, Rossi, Elisa, Cinconze, Elisa, Gasbarrini, Antonio, Monici Preti, PierAlessandro, De Rosa, Marisa

“…Hepatic encephalopathy (HE) is a recurrent severe complication of progressive hepatic cirrhosis. The aim of this study is to evaluate the average annual direct…”
Get full text

Efficacy and tolerability of brodimoprim in bacterial otitis media in children. Controlled study versus cefaclor by Galetti, G, Martini, A, Bergamini, G, Dallari, S, Ghidini, A, Mazzoli, M, Cantini, L, Monici Preti, P A

“…78 pediatric patients affected by acute otitis media were selected and randomized into two balanced groups of treatment: brodimoprim, at the dosage of 200 mg…”
Get more information

Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation by Dal Negro, R, Turco, P, Pomari, C, Monici-Preti, P

“…Theophylline plasma levels and FEV1 were measured in patients affected by chronic obstructive pulmonary disease and a concomitant disease state (congestive…”
Get more information

184 Aerosolized tobramycin in the treatment of patients with Cystic Fibrosis and Pseudomonas aeruginosa infection by Lenoir, G., Aryayev, N., Varoli, G., Monici Preti, P.

Get full text

Protection against non-specific bronchial hyperreactivity and bronchodilating action of procaterol in atopics by Dal Negro, R W, Zoccatelli, O, Pomari, C, Turco, P, Monici Pretti, P

“…The efficacy of procaterol, a new selective beta 2-stimulant (by pressurized aerosol), and its protection against the effects of non-specific bronchial…”
Get more information

A double blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses by Finzi, A, Fioroni, A, Monici Preti, P, Mounari, M

Get more information

Treatment of dermatomycoses with topical fenticonazole and econazole by Kokoschka, E M, Niebauer, G, Mounari, M, Monici Preti, P

Get more information

Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial by Bevilacqua, G, Parmigiani, S, Robertson, B

“…The objective of this prospective, multicentre trial, carried out at 18 third level hospitals in Italy, was to evaluate efficacy of modified porcine surfactant…”
Get more information

Efficacy and tolerability of brodimorphin at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis : comparative study vs. pefloxacin by COSMI, E. V, CANTINI, L, MEARINI, L, MINOZZI, M, SCARPELLO, F, MONICI PRETI, P. A, DI RENZO, G. C, ABATE, F, BALSOTTI, G, CARLOMAGNO, G, CIRESE, E, INDRACCOLO, R, LA SALA, G. B

Get full text

The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population by Maresta, A, Balducelli, M, Cantini, L, Casari, A, Chioin, R, Fontanelli, A, Monici Preti, P A, Repetto, S, Raffaghello, S

“…Restenosis remains the principal drawback of percutaneous transluminal coronary angioplasty (PTCA) since 30-35% of patients still experience it 6 months after…”
Get more information

Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day by Caputi, M, Cautiero, V, Aliberti, M, Monici Preti, P A, Oliani, C

Get more information

Evaluation of the skin retention time of imidazole derivatives by Veronese, M, Bertoncini, A, Preti, P M

Get more information